Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 5.42 is 27% above its 1-year average of 4.27, near the high end of its 1-year range (0.00–7.40).
As of the fiscal period ended Tuesday, June 30, 2026. 15.43% below its 12-month average of 6.41.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.42.
CURRENT RATIO
5.42
CURRENT RATIO AVG TTM
6.41
CURRENT RATIO AVG 3Y
N/A
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-15.43%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.36
median of 505 covered companies
CURRENT VS SECTOR MEDIAN
+61.38%
vs the sector median at left
BlossomHill Therapeutics, Inc.
Market Cap
$579.88M
Current Ratio
5.42
TTM Avg
6.41
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$573.38M
Current Ratio
7.19
TTM Avg
3.91
3Y Avg
2.77
5Y Avg
2.56
Market Cap
$596.36M
Current Ratio
3.46
TTM Avg
4.63
3Y Avg
6.00
5Y Avg
6.13
Market Cap
$561.67M
Current Ratio
9.36
TTM Avg
2.17
3Y Avg
1.76
5Y Avg
2.63
Market Cap
$600.84M
Current Ratio
6.06
TTM Avg
2.91
3Y Avg
9.31
5Y Avg
9.54
Market Cap
$551.09M
Current Ratio
25.13
TTM Avg
6.17
3Y Avg
7.34
5Y Avg
19.91
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BlossomHill Therapeutics, Inc. (BLSM) | $579.88M | 5.42 | 6.41 | N/A | N/A |
| Aquestive Therapeutics, Inc. (AQST)vs › | $573.38M | 7.19 | 3.91 | 2.77 | 2.56 |
| OrthoPediatrics Corp. (KIDS)vs › | $587.93M | 4.78 | 6.27 | 6.33 | 5.72 |
| CorMedix Inc. (CRMD)vs › | $569.56M | 2.56 | 2.75 | 5.48 | 7.66 |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $596.36M | 3.46 | 4.63 | 6.00 | 6.13 |
| CytomX Therapeutics, Inc. (CTMX)vs › | $561.67M | 9.36 | 2.17 | 1.76 | 2.63 |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $600.84M | 6.06 | 2.91 | 9.31 | 9.54 |
| Immix Biopharma, Inc. (IMMX)vs › | $551.09M | 25.13 | 6.17 | 7.34 | 19.91 |
| Delcath Systems, Inc. (DCTH)vs › | $547.86M | 9.83 | 11.46 | 6.57 | 5.79 |
| Climb Bio, Inc. (CLYM)vs › | $632.76M | 31.45 | 23.29 | 26.88 | 23.21 |
Current Ratio
5.42
Quick Ratio
5.42
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 5.42 |
| 2026-03-31 | 7.40 |
| 2025-03-31 | 0.00 |
